Company page

Senhwa Biosciences Inc

Senhwa Biosciences Inc, trading under the ticker 6492, is a publicly listed company on the Taiwan market with a market capitalization of approximately 124.7 million USD. The company focuses on developing innovative therapies in the biopharmaceutical sector. Senhwa is committed to advancing healthcare solutions and improving patient outcomes through its research and development efforts.